Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy

Anupam Mittal1, Rajni Garg2, Ajay Bahl3

  • 1Department of Translational and Regenerative Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Insights

Type 2 diabetes contributes to cardiovascular issues like diabetic cardiomyopathy (DbCM). This review explores how epigenetic modifications, including DNA methylation and non-coding RNAs, influence DbCM development and progression.

Area of Science:

  • Cardiovascular Science
  • Metabolic Disorders
  • Epigenetics

Background:

  • Type 2 diabetes mellitus (DM) is a major lifestyle disease linked to cardiovascular diseases (CVD).
  • Diabetic cardiomyopathy (DbCM) is a cardiac complication of DM, characterized by cardiac remodeling independent of other comorbidities.
  • DbCM involves impaired cardiac metabolism, mitochondrial dysfunction, oxidative stress, inflammation, apoptosis, and autophagy.

Purpose of the Study:

  • To review the role of epigenetic modifications in the pathogenesis of diabetic cardiomyopathy (DbCM).
  • To elucidate how epigenetic mechanisms regulate molecular pathways involved in DbCM.

Main Methods:

  • Literature review focusing on epigenetic mechanisms in DbCM.
  • Analysis of studies investigating histone modifications (acetylation, methylation), DNA methylation, and non-coding RNAs in DbCM.

Main Results:

  • Epigenetic modifiers are critical in DbCM development.
  • Histone modifications, DNA methylation, and non-coding RNAs significantly impact molecular pathways underlying DbCM pathophysiology.

Conclusions:

  • Epigenetic modifications play a crucial role in the development and progression of diabetic cardiomyopathy.
  • Targeting epigenetic mechanisms offers potential therapeutic strategies for managing DbCM in diabetic patients.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
376
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
86
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
87